Observational studyArthritis research & therapy2024

Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort.

Roberta Ramonda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.